Respiratory Infections Flashcards
Streptococcus pneumoniae
Haemophilus influenzae
Moraxella catarrhalis
Typical bacteria
Mycoplasma pneumoniae
Chlamydophila pneumoniae
Atypical bacteria
Influenza, adenovirus, RSV, parainfluenza
Respiratory viruses
Typical bacteria presentaion
-High fever, productive cough, consolidated infiltrates, rapid onset
Atypical bacteria presentation
Mild fever, non-productive cough, diffuse or patchy infiltrates, slower onset
If use of antimicrobials within the previous 3 months………
AVOID same class antibiotics!!
Risk Factors for Drug Resistant
S. pneumoniae (DRSP)
Age >65 years β-lactam, macrolide, or fluoroquinolone therapy within the past 3 months Alcoholism Multiple medical comorbidities Immunosuppressive illness or therapy Exposure to a child in a day care
Previously healthy, no use of antimicrobials within past 3 months, outpatient CAP tx
Macrolide (azithromycin, clarithromycin)
OR
Doxycycline
Presence of comorbidities or previous antimicrobial use within past 3 months or risk factors for DRSP outpatient tx
Respiratory fluoroquinolone (moxifloxacin, gemifloxacin, levofloxacin)
OR
[Amoxicillin/clavulanate or cephalosporin] + macrolide
OR
[Amoxicillin/clavulanate or cephalosporin] + doxycycline
If Pseudomonas is suspected (based on comorbidities): COPD Structural lung disease Smoking outpatient tx
Levofloxacin (750 mg daily, high dose)
OR
Consider IV antipseudomonal β-lactam
Outpatient CAP if hx of alcoholism
Amoxicillin/clavulanate OR Cephalosporin + clindamycin OR Respiratory fluoroquinolone
Outpatient CAP if aspiration suspected
Amoxicillin/clavulanate OR Moxifloxacin OR Clindamycin
Drugs for pseudomonas coverage
Cefepime, zosyn, carbapenems
Drugs for MRSA coverage
Vancomycin or linezolid
HAP empiric tx
Should always cover MRSA & P. Aeruginosa & GNRs
-Pseudomonas & MRSA coverage
HAP empiric tx if prior IV abx use in last 90 days or high risk for mortality
- 2 anti-pseudomonal agents
- Cefepmie & tobramycin
- Pip/taxo & levofloxacin
- Do not use 2 beta lactams!!!
VAP organisms
- Staphylococcus aureus (20-30% of isolates)
- Pseudomonas aeruginosa (10-20% of isolates)
- Acinetobacter baumannii (5-10% of isolates) - very high resistance rates!!
Duration of therapy
8-15 days
Higher % of multidrbg-resistance seen with longer tx duration
Whooping cough
Persistent cough >14 days
Uncommon occurrence
High probability of exposure during outbreak
R/O asthma, GERD, Post-nasal drip
Antibiotic therapy aimed at eradicating nasal carriage
Bordetella pertussis
Bordetelle pertussis children tx
- Erythromycin estolate PO
- Erythromycin base PO
- Azithromycin
- Clarithromycin
- Isolate pt 5 days from start of tx!
Bordetella pertussis adult tx
- Azithromycin
- Erythromycin estolate
- Bactrim (TMP/SMX)
- Clarithromycin
- Isolate pt 5 days from start of tx!
Most common typical bacteria
H. Influenzae
Common viral pathogens
- Rhinovirus
- Influenza A & B
- Parainfluenza
- Coronavirus
- Respiratory syncytial virus (RSV)
- Adenovirus
Treatment of AECB
ABC approach
- Antibiotics
- Bronchodilators
- Corticosteroids